This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Renal Diseases, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Laura C. Plantinga, ScM; L. Ebony Boulware, MD, MPH; Lesley A. Stevens, MD, MS; Edgar R. Miller III, MD, PhD; Neil R. Powe, MD, MPH, MBA

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We appreciate the comments of Dr Mann. First, we recognize that eGFR is not a perfect measure of kidney function and that there is some debate about its utility in the detection of CKD.¹ However, it should be noted that we found that awareness was still low among those with more severe declines in eGFR (eg, patients with CKD stage 3B or 4), in whom prediction equations perform better² and who have even greater reason to be aware of their disease. Also, because eGFR is currently the most accurate, as well as the least expensive and most feasible, measure of kidney function in clinical practice, we believe that eGFR measurement was appropriate for our study.

We also agree that there could be . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?